Novartis AG
SIX:NOVN
Novartis AG
Tax Provision
Novartis AG
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Novartis AG
SIX:NOVN
|
Tax Provision
-$992m
|
CAGR 3-Years
17%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Tax Provision
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Roche Holding AG
SIX:ROG
|
Tax Provision
-CHf1.7B
|
CAGR 3-Years
16%
|
CAGR 5-Years
12%
|
CAGR 10-Years
6%
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Tax Provision
-$252m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Novartis AG's Tax Provision?
Tax Provision
-992m
USD
Based on the financial report for Mar 31, 2024, Novartis AG's Tax Provision amounts to -992m USD.
What is Novartis AG's Tax Provision growth rate?
Tax Provision CAGR 10Y
4%
Over the last year, the Tax Provision growth was 30%. The average annual Tax Provision growth rates for Novartis AG have been 17% over the past three years , 4% over the past five years , and 4% over the past ten years .